First Capital Advisors Group’s United Therapeutics UTHR Stock Holding History

First Capital Advisors Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.31K	Buy	+15	New	+$3.32K	﹤0.01%	724

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Capital Advisors Group's UTHR Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in United Therapeutics (UTHR) in Q2 2023: 15 shares worth $3.31K. The stake represents ﹤0.01% of the portfolio and ranks #724 among its holdings.

475 funds tracked by Wall St. Rank hold UTHR as of Q2 2023.

First Capital Advisors Group held 15 shares of United Therapeutics worth $3.31K as of Q2 2023.
United Therapeutics was a new First Capital Advisors Group position in Q2 2023.
United Therapeutics made up ﹤0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #724 holding.
475 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.